학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 2,743건 | 목록 1~10
Academic Journal
Facchinetti F; Institut Gustave Roussy, Villejuif, France.; Loriot Y; Institut de Cancérologie Gustave Roussy, Villejuif, France.; Braye F; Institut Gustave Roussy, Villejuif, France.; Vasseur D; Institut Gustave Roussy, Villejuif, France.; Bahleda R; Institut Gustave Roussy, Villejuif, France.; Bigot L; Institut Gustave Roussy, Villejuif, France.; Barbé R; Institut Gustave Roussy, France.; Nobre C; Institut Gustave Roussy, France.; Combarel D; Institut Gustave Roussy, Villejuif, France.; Michiels S; Institut Gustave Roussy, Villejuif, France.; Italiano A; Institut Bergonié, Bordeaux, France.; Smolenschi C; Institut Gustave Roussy, VILLEJUIF, France.; Tselikas L; Institut Gustave Roussy, Villejuif, France.; Scoazec JY; Institut Gustave Roussy, Villejuif, Ile de France, France.; Ponce-Aix S; Institut Gustave Roussy, Villejuif, France.; Besse B; Institut Gustave Roussy, Villejuif, France.; Andre F; Institut Gustave Roussy, villejuif, France.; Olaussen KA; University of Paris-Saclay, Villejuif, France.; Hollebecque A; Institut Gustave Roussy, Villejuif, France.; Friboulet L; Institut Gustave Roussy, Villejuif, France.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Felip E; Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), UVic-UCC, IOB-Quiron, Barcelona, Spain. Electronic address: efelip@vhio.net.; Metro G; Medical Oncology, Santa Maria della Misericordia Hospital, Azienda Ospedaliero-Universitaria di Perugia, Perugia, Italy.; Soo RA; National University Cancer Institute Singapore, Singapore.; Wolf J; Department of Internal Medicine, Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany.; Solomon BJ; Peter MacCallum Cancer Centre, Melbourne, Australia.; Tan DS; National Cancer Centre, Duke-NUS Medical School, Singapore.; Ardizzoni A; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Lee DH; Asan Medical Center, Seoul, Republic of Korea.; Sequist LV; Massachusetts General Hospital, Boston, MA, USA.; Barlesi F; Aix Marseille University, CNRS, INSERM, CRCM, APHM, CEPCM CLIP, Marseille, France; Medical Oncology department, Gustave Roussy, Villejuif, France; Université Paris Saclay, Faculté de Médecine, Kremlin Bicêtre, Gustave Roussy, Villejuif, France.; Ponce-Aix S; Hospital Universitario 12 De Octubre, Madrid, Spain; Early Drug Development Department, Gustave Roussy, Villejuif, France.; Abreu DR; Complejo Hospitalario Universitario Insular-Materno Infantil de Gran Canaria, Universidad de Las Palmas de Gran Canaria, Spain.; Campelo MRG; Complejo Hospitalario Universitario A Coruña, La Coruña, Spain.; Sprauten M; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Djentuh LO; Novartis Pharma AG, Basel, Switzerland.; Smith N; Novartis Pharma AG, Basel, Switzerland.; Jary A; Novartis Pharma AG, Basel, Switzerland.; Belli R; Novartis Pharma AG, Basel, Switzerland.; Glaser S; Novartis Pharma AG, Basel, Switzerland.; Zou M; Novartis Services Inc., East Hanover, NJ, USA.; Cui X; Novartis Institutes for BioMedical Research, East Hanover, NJ, USA.; Giovannini M; Novartis Services Inc., East Hanover, NJ, USA.; Yang JC; National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Academic Journal
Peressini M; Tumor Microenvironment and Immunotherapy Research Group, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain.; Garcia-Campelo R; Department of Medical Oncology, Hospital Universitario de A Coruña, A Coruña, Spain.; Massuti B; Department of Medical Oncology, Hospital General Universitario de Alicante, Alicante, Spain.; Martí C; Department of Medical Oncology, Hospital Universitario Sant Joan de Reus, Tarragona, Spain.; Cobo M; Department of Medical Oncology, UGC intercentros de Oncología Médica, Hospitales Universitarios Regional y Virgen de la Victoria, IBIMA, Málaga, Spain.; Gutiérrez V; Department of Medical Oncology, Complejo Hospitalario Regional de Málaga, Málaga, Spain.; Dómine M; Department of Medical Oncology, Hospital Universitario Fundación Jimenez Díaz, Madrid, Spain.; Fuentes J; Department of Medical Oncology, Hospital Universitario Virgen de Valme, Sevilla, Spain.; Majem M; Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; de Castro J; Department of Medical Oncology, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.; Córdoba JF; Department of Medical Oncology, Hospital Universitario Arnau de Villanova, Lérida, Spain.; Diz MP; Department of Medical Oncology, Complejo Asistencial Universitario de León, León, Spain.; Isla D; Department of Medical Oncology, Hospital Universitario Lozano Blesa, Zaragoza, Spain.; Esteban E; Department of Medical Oncology, Hospital Universitario Central de Asturias, Asturias, Spain.; Carcereny E; Department of Medical Oncology, Instituto Catalán de Oncología de Badalona, Badalona-Applied Research Group in Oncology (B-ARGO), Barcelona, Spain.; Vila L; Department of Medical Oncology, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Barcelona, Spain.; Moreno-Vega A; Department of Medical Oncology, Hospital Universitario Reina Sofia, Córdoba, Spain.; Ros S; Department of Medical Oncology, Hospital Universitario Virgen de La Arrixaca, Murcia, Spain.; Moreno A; Department of Medical Oncology, Hospital de Galdakao, Vizcaya, Spain.; García FJ; Department of Medical Oncology, Hospital Universitario Son Llatzer, Mallorca, Spain.; Huidobro G; Department of Medical Oncology, Hospital Universitario Álvaro Cunqueiro, Vigo, Spain.; Aguado C; Department of Medical Oncology, Hospital Universitario Clínico San Carlos, Madrid, Spain.; Cebey-López V; Department of Medical Oncology, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain.; Valdivia J; Department of Medical Oncology, Hospital Universitario Virgen de las Nieves, Granada, Spain.; Palmero R; Department of Medical Oncology, Instituto Catalán de Oncología de Hospitalet de Llobregat, Barcelona, Spain.; Lianes P; Department of Medical Oncology, Hospital de Mataró, Barcelona, Spain.; López-Brea M; Department of Medical Oncology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.; Vidal OJ; Department of Medical Oncology, Hospital Universitario La Fe, Valencia, Spain.; Provencio M; Department of Medical Oncology, Hospital Universitario Puerta de Hierro, Madrid, Spain.; Arriola E; Department of Medical Oncology, Hospital del Mar, Barcelona, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Baena J; Tumor Microenvironment and Immunotherapy Research Group, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain.; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Herrera M; Tumor Microenvironment and Immunotherapy Research Group, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain.; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Bote H; Tumor Microenvironment and Immunotherapy Research Group, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain.; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Molero M; Tumor Microenvironment and Immunotherapy Research Group, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Adradas V; Tumor Microenvironment and Immunotherapy Research Group, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Ponce-Aix S; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Nuñez-Buiza A; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Ucero Á; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Department of Physiology, Complutense University, Madrid, Spain.; Hernandez S; Department of Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Lopez-Rios F; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Department of Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Legal Medicine, Psychiatry and Pathology, Complutense University, Madrid, Spain.; Conde E; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Department of Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Legal Medicine, Psychiatry and Pathology, Complutense University, Madrid, Spain.; Paz-Ares L; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Department of Physiology, Complutense University, Madrid, Spain.; Department of Medicine, Complutense University, Madrid, Spain.; Zugazagoitia J; Tumor Microenvironment and Immunotherapy Research Group, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.
Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Rached L; Gustave Roussy, Department of Therapeutic Innovations and Early Trials, 94805 Villejuif, France.; Laparra A; Gustave Roussy, Interdisciplinary Department for the Organization of Patient Pathways, 94805 Villejuif, France.; Sakkal M; Gustave Roussy, Department of Therapeutic Innovations and Early Trials, 94805 Villejuif, France.; Danlos FX; Gustave Roussy, Department of Therapeutic Innovations and Early Trials, 94805 Villejuif, France.; Barlesi F; Paris Saclay University and Gustave Roussy, Department of Medical Oncology, 94805 Villejuif, France.; Carbonnel F; University Hospital of Bicêtre and Université Paris-Saclay, Department of Gastroenterology, 94270 Le Kremlin Bicêtre, France.; De Martin E; AP-HP Paul-Brousse Hospital, Hepato-Biliary Center, Inserm Unit 1193, Paris-Saclay University, Hepatinov FHU, Reference Center for Inflammatory Biliary Tract Diseases and Autoimmune Hepatitis, Villejuif, France.; Ducreux M; Paris Saclay University and Gustave Roussy, Department of Medical Oncology, 94805 Villejuif, France.; Even C; Paris Saclay University and Gustave Roussy, Department of Medical Oncology, 94805 Villejuif, France.; Le Pavec J; Paris-Saclay University, Faculty of Medicine, INSERM UMR_S999, 94270 Le Kremlin-Bicêtre, France; Pneumology and Lung Transplant Department, Marie-Lannelongue Hospital, Le Plessis-Robinson, France.; Michot JM; Gustave Roussy, Department of Therapeutic Innovations and Early Trials, 94805 Villejuif, France.; M Ribeiro J; Paris Saclay University and Gustave Roussy, Department of Medical Oncology, 94805 Villejuif, France.; Scotte F; Gustave Roussy, Interdisciplinary Department for the Organization of Patient Pathways, 94805 Villejuif, France.; Ponce Aix S; Gustave Roussy, Department of Therapeutic Innovations and Early Trials, 94805 Villejuif, France.; Lambotte O; University Paris Saclay, GHU AP-HP Paris Saclay, Department of Internal Medicine and Clinical Immunology, Bicêtre Hospital, UMR1184 CEA, Inserm, Kremlin Bicêtre, France.; Baldini C; Gustave Roussy, Department of Therapeutic Innovations and Early Trials, 94805 Villejuif, France.; Champiat S; Gustave Roussy, Department of Therapeutic Innovations and Early Trials, 94805 Villejuif, France. Electronic address: Stephane.champiat@gustaveroussy.fr.
Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7502030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1967 (Electronic) Linking ISSN: 03057372 NLM ISO Abbreviation: Cancer Treat Rev Subsets: MEDLINE
Academic Journal
Blanc-Durand F; Medical Oncology Department, Institut Gustave Roussy, Villejuif, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) U981, Institut Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Camilleri GM; Medical Oncology Department, Institut Gustave Roussy, Villejuif, France.; Bayle A; Bureau Biostatistique et Épidémiologie, Institut Gustave Roussy, Université Paris-Saclay, Villejuif, France.; INSERM, Université Paris-Saclay, CESP U1018 Oncostat, Labelisé Ligue Contre le Cancer, Villejuif, France.; Aldea M; Medical Oncology Department, Institut Gustave Roussy, Villejuif, France.; Vasseur D; Cancer Genetics Unit, Department of Biology and Pathology, Institut Gustave Roussy, Villejuif, France.; Ouali K; Drug Development Department, Institut Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Michels J; Medical Oncology Department, Institut Gustave Roussy, Villejuif, France.; Pautier P; Medical Oncology Department, Institut Gustave Roussy, Villejuif, France.; Nicotra C; Drug Development Department, Institut Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Ngo-Camus M; Drug Development Department, Institut Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Lacroix L; Cancer Genetics Unit, Department of Biology and Pathology, Institut Gustave Roussy, Villejuif, France.; Rouleau E; Cancer Genetics Unit, Department of Biology and Pathology, Institut Gustave Roussy, Villejuif, France.; Ponce-Aix S; Drug Development Department, Institut Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Italiano A; Drug Development Department, Institut Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Leary A; Medical Oncology Department, Institut Gustave Roussy, Villejuif, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) U981, Institut Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Ponce Aix, S.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어